With the potential wide uses of nanoparticles such as carbon nanotubes in biomedical applications, and the growing concerns of nanotoxicity of these engineered nanoparticles, the importance of nanoparticle-protein interactions cannot be stressed enough. In this study, we use both experimental and theoretical approaches, including atomic force microscope images, fluorescence spectroscopy, CD, SDS-PAGE, and molecular dynamics simulations, to investigate the interactions of single-wall carbon nanotubes (SWCNTs) with human serum proteins, and find a competitive binding of these proteins with different adsorption capacity and packing modes. The π-π stacking interactions between SWCNTs and aromatic residues (Trp, Phe, Tyr) are found to play a critical role in determining their adsorption capacity. Additional cellular cytotoxicity assays, with human acute monocytic leukemia cell line and human umbilical vein endothelial cells, reveal that the competitive bindings of blood proteins on the SWCNT surface can greatly alter their cellular interaction pathways and result in much reduced cytotoxicity for these protein-coated SWCNTs, according to their respective adsorption capacity. These findings have shed light toward the design of safe carbon nanotube nanomaterials by comprehensive preconsideration of their interactions with human serum proteins.competitive adsorption | nanoparticle-protein corona | hydrophobic interactions | conformational flexibility C arbon nanotubes (CNTs) have a broad range of potential applications, including nanoelectronics (1), biosensors (2), biomolecular recognition devices and molecular transporters (3, 4), and cancer therapy and diagnoses (5-7), because of their extraordinary mechanical, electronic, optical, geometric, and biological properties. Both the pharmacological (8, 9) and toxicological (10-15) profiles of CNTs have attracted much attention in recent years. Nanomedicine provides a great potential in fighting many diseases but a global effort is much needed to safely translate laboratory innovations into clinic trials. Seven grand challenges have been proposed for this endeavor (16). CNTbased multimodality imaging and therapy have been proposed for a variety of medical applications, such as carriers for chemotherapeutic drugs (17, 18), Raman detection and imaging (19,20), photoacoustic imaging, and photothermal therapy of cancers (6, 21). Meanwhile, of equal importance there is the emerging field of nanotoxicology, which aims to address the biosafety of these engineered nanoparticles, in particular, how these nanoparticles interact with human proteins in vivo (22)(23)(24)(25).Many studies have been performed on the biological effects of carbon nanotubes, and the interactions between proteins and CNTs (nanoparticle-protein corona) are believed to play an important role in the biological effects of CNTs (26-28). For example, CNTs could bind with pulmonary surfactant proteins A and D and then lead to susceptibility of lung infection and emphysema in mice (29). When the functionalized CNTs w...

No abstract

We have observed that Au nanorods (NRs) have distinct effects on cell viability via killing cancer cells while posing negligible impact on normal cells and mesenchymal stem cells. Obvious differences in cellular uptake, intracellular trafficking, and susceptibility of lysosome to Au NRs by different types of cells resulted in selective accumulation of Au NRs in the mitochondria of cancer cells. Their long-term retention decreased mitochondrial membrane potential and increased reactive oxygen species level that enhances the likelihood of cell death. These findings thus provide guidance for the design of organelle-targeted nanomaterials in tumor therapy.